SHAPING THE FUTURE OF
n (Life Sciences & Allied Applications / Biology) the mimicking of life using imitation biological systems
The article “Cost-effectiveness of superﬁcial femoral artery endovascular interventions in the UK and Germany: a modelling study” has been published in the British medical Journal (BMJ.)
The lead author is Benjamin Kearns, a research fellow at Sheffield University. UK and German healthcare perspectives and costs were considered within the study, as were different strategies for reintervention. The main conclusion is that BioMimics 3D was “always estimated to dominate the other (SFA) interventions, having lower lifetime costs and greater effectiveness, as measured by quality-adjusted life years (QALYs)”.
Follow this link to access the article: BMJ and this link B. Kearns audio to hear a presentation by the lead author.
VERYAN’S VASCULAR BIOMIMETIC STENT
IMPROVING PERFORMANCE BY IMITATING THE NATURAL 3D HELICAL SHAPE OF THE VASCULAR SYSTEM
Veryan has developed innovative technology to improve the performance of vascular stents by adopting the principle of biomimicry; developing structures that imitate those occurring naturally. Veryan’s vascular biomimetic stent technology involves adapting a straight stent design to a three-dimensional helical shape, which more closely mimics the natural geometry of the human vascular system. The BioMimics 3D stent belongs to a new generation of self-expanding stent design with advanced biomechanical and flow performance properties, creating the potential to transform the treatment of patients with symptomatic peripheral arterial disease of the lower limbs. This highly differentiated technology has been clinically proven in a multicentre, randomised clinical trial (the Mimics study) in superficial femoral and proximal popliteal (femoropopliteral) arteries of the leg and received CE Mark approval in November 2012.